Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
EMD-386088 is a tetrahydropyridinylindole derivative primarily utilized in scientific research. It functions as a potent partial agonist of the 5-HT6 receptor. Additionally, it acts as a dopamine reuptake inhibitor, an action believed to contribute to its antidepressant-like effects observed in rodent studies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on EMD-386088.